Literature DB >> 12579632

Incontinent ileovesicostomy in the management of neurogenic bladder dysfunction.

Anthony R Gauthier1, J Christian Winters.   

Abstract

AIMS: To report outcome and urodynamic follow-up of incontinent ileovesicostomy in quadriplegic patients with neurogenic bladder.
METHODS: Seven patients (five male, two female; mean age, 33.7 yr) with neurogenic bladder underwent ileovesicostomy for management of leakage or complications of chronic catheter drainage. Five had chronic indwelling catheters: three suprapubic and two urethral. Preoperatively, all had upper tract evaluation and videourodynamics. All seven patients had detrusor hyperreflexia. Preoperative detrusor leak point pressures averaged 42.7 cm H(2)O. Two females had intrinsic sphincteric deficiency from prolonged Foley catheter drainage. Ileovesicostomy involves isolation of a 15-20-cm segment of terminal ileum. The proximal 6-8 cm of this segment is opened on the antimesenteric border. The dome of the bladder is opened widely in a transverse manner and the proximal portion of the bowel is sutured onto the bladder. The distal portion of the ileum remains tubularized and becomes the stoma.
RESULTS: There were no intraoperative complications. Operative time averaged 159 minutes. Associated procedures included removal of bladder calculus (n = 1), pubovaginal sling (n = 2), and Marshall Marchetti Krantz suspension (n = 1). Mean blood loss was <200 cc in six patients. Mean hospital stay was 8 days. Complications in two patients included: fascial stenosis requiring stoma revision (n = 1), wound infection (n = 1), and postoperative ileus (n = 1). Mean follow-up was 37.4 months. Postoperatively, mean detrusor leak point pressures were 16.7 cm H(2)O (P = 0.0061). Patient satisfaction is high with only one complaint of occasional difficulty fitting the appliance.
CONCLUSIONS: Ileovesicostomy is an effective method of urinary drainage in quadriplegic patients. Detrusor leak point pressures were lowered, and upper tracts were preserved. No long-term complications were encountered. Copyright 2003 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2003        PMID: 12579632     DOI: 10.1002/nau.10093

Source DB:  PubMed          Journal:  Neurourol Urodyn        ISSN: 0733-2467            Impact factor:   2.696


  9 in total

1.  Recent publications by ochsner authors.

Authors: 
Journal:  Ochsner J       Date:  2003

2.  Voiding dysfunction after pelvic colorectal surgery.

Authors:  Scott E Delacroix; J C Winters
Journal:  Clin Colon Rectal Surg       Date:  2010-06

3.  Neurogenic bladder: management of the severely impaired patient with complete urethral destruction: ileovesicostomy, suprapubic tube drainage or urinary diversion-is one treatment modality better than another?

Authors:  Douglas A Husmann; Boyd R Viers
Journal:  Transl Androl Urol       Date:  2020-02

Review 4.  Evaluation and management of refractory overactive bladder.

Authors:  Humphrey O Atiemo; Sandip P Vasavada
Journal:  Curr Urol Rep       Date:  2006-09       Impact factor: 2.862

5.  Completely intracorporeal robotic-assisted laparoscopic ileovesicostomy.

Authors:  Maryellen T Dolat; Greg Wade; B Mayer Grob; Lance J Hampton; Adam P Klausner
Journal:  Case Rep Urol       Date:  2014-01-29

6.  Completely intracorporeal robotic-assisted laparoscopic ileovesicostomy: initial results.

Authors:  MaryEllen T Dolat; Blake W Moore; B Mayer Grob; Adam P Klausner; Lance J Hampton
Journal:  J Robot Surg       Date:  2014-01-30

7.  Ileovesicostomy update: changes for the 21st century.

Authors:  W Britt Zimmerman; Richard A Santucci
Journal:  Adv Urol       Date:  2009-10-27

8.  Urinary undiversion by conversion of the incontinent ileovesicostomy to augmentation ileocystoplasty in spinal cord injured patients.

Authors:  Patrick J Shenot; Seth Teplitsky; Andrew Margules; Aaron Miller; Akhil K Das
Journal:  J Spinal Cord Med       Date:  2020-10-15       Impact factor: 2.040

9.  Long-term outcomes of urinary tract reconstruction in patients with neurogenic urinary tract dysfunction.

Authors:  E U Johnson; Gurpreet Singh
Journal:  Indian J Urol       Date:  2013-10
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.